ACRV
#4019
Acrivon Therapeutics, Inc. - Common Stock
1.9 8 USD
+0.08%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+7.58%
Variación mensual
+30.26%
Variación en los últimos 6 meses
+2.59%
Cambio anual
+53.49%
Cierres anteriores
2.1 3
Open
2.1 0
Mínimo
1.9 8
High
2.1 1
Volumen
112
Financials
- Market Capitalization 84.75 M
- Employee 76
- Founded 2018
- CEO N/A
- Website www.acrivon.com
- Headquarter Massachusetts, United States
- FIGI BBG011RWR2Q4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3998 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.17 USD | +0.86% | -2.50% | +5.41% | -11.36% | 96.26 M USD | ||
| 4011 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.28 USD | -0.78% | -3.03% | +6.67% | -30.81% | 92.54 M USD | ||
| 4023 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.98 USD | -2.97% | -8.41% | -19.67% | +53.12% | 87.71 M USD | ||
| 4031 |  CRDF Cardiff Oncology, Inc. - Common Stock | 0.88 USD | -32.82% | -33.83% | -39.31% | -78.69% | 60.17 M USD |